Your session is about to expire
← Back to Search
PRISM for Cancer (PRISM-AC Trial)
N/A
Waitlist Available
Led By Abby R Rosenberg, MD, MS, MA
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 12-24 years
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-months
Awards & highlights
PRISM-AC Trial Summary
This trial is testing whether the PRISM intervention can help adolescents and young adults with advanced cancer manage stress.
Who is the study for?
This trial is for adolescents and young adults aged 12-24 with advanced cancer, who can speak and read English or Spanish. They should be cognitively able to participate in interviews. It's not open to those whose parents refuse participation (if under 18) or if the patient themselves refuses.Check my eligibility
What is being tested?
The PRISM intervention is being tested in this study across multiple sites. The goal of PRISM is to help these young individuals manage stress, improve resilience, and enhance their quality of life while dealing with advanced cancer.See study design
What are the potential side effects?
Since PRISM focuses on stress management techniques rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing personal topics during sessions.
PRISM-AC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 12 and 24 years old.
PRISM-AC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
PedsQL Generic Core and Cancer-Specific Quality of Life scores
Secondary outcome measures
Connor Davidson Resilience Scale
Hope scale score
Hospital Anxiety and Depression Scale (HADS) score
+5 morePRISM-AC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Promoting Resilience in Stress Management (PRISM)Experimental Treatment1 Intervention
Resilience Skills Training
Group II: Usual CareActive Control1 Intervention
Standard psychosocial care
Find a Location
Who is running the clinical trial?
Pittsburgh Children's HospitalUNKNOWN
Children's Hospital Los AngelesOTHER
232 Previous Clinical Trials
5,076,574 Total Patients Enrolled
3 Trials studying Depression
116 Patients Enrolled for Depression
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,959 Total Patients Enrolled
81 Trials studying Depression
65,913 Patients Enrolled for Depression
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 12 and 24 years old.My advanced cancer is getting worse or not responding to treatment.I have chosen not to participate in certain treatments.My parents have not refused participation in the trial.I am mentally capable of participating in interviews.You are able to read and write in English or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: Promoting Resilience in Stress Management (PRISM)
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Would this research be able to include people over the age of 40?
"This study is open to adolescents aged 12-24 years old."
Answered by AI
Does this clinical trial have a broad geographic distribution in Canada?
"Currently, this trial is enrolling patients from 4 clinical sites. Two of these sites are in California (Los Angeles and San Francisco), one is in Texas (Houston), and one is in Pennsylvania (Pittsburgh). To help participants, the team running this trial suggests selecting the location closest to them to limit travel requirements."
Answered by AI
Out of the total number of people participating in this trial, how many are receiving the active treatment?
"That is correct. The clinical trial is recruiting patients at this time. Information on clinicaltrials.gov shows that the trial was first posted on 4/15/2019 and was last edited on 6/7/2022. The trial is looking for 195 patients at 4 different sites."
Answered by AI
Does PRISM have the FDA's official backing?
"While there is some efficacy data for PRISM, it is primarily the safety data that has been collected over multiple rounds that has led our team to rate it a 3."
Answered by AI
Who else is applying?
What state do they live in?
California
Texas
How old are they?
18 - 65
What site did they apply to?
Children's Hospital Los Angeles
Texas Children's Hospital
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger